Valuation : Embecta Corp.

Market Cap 277M 238M 225M 205M 383M 26.49B 386M 2.68B 1.03B 13.44B 1.04B 1.02B 42.68B P/E 2026 *
4.13x
P/E 2027 * 3.54x
Enterprise Value 277M 238M 225M 205M 383M 26.49B 386M 2.68B 1.03B 13.44B 1.04B 1.02B 42.68B EV / Sales 2026 *
0.27x
EV / Sales 2027 * 0.26x
Free-Float
97.99%
Yield 2026 *
5.15%
Yield 2027 * 0.83%
1 day+1.33%
1 week-14.74%
Current month-3.79%
1 month+1.33%
3 months+60.55%
6 months-45.06%
Current year-58.38%
1 week 4.87
Extreme 4.87
5.76
1 month 4.63
Extreme 4.63
5.91
Current year 2.77
Extreme 2.77
13.44
1 year 2.77
Extreme 2.77
15.55
3 years 2.77
Extreme 2.77
21.48
5 years 0
Extreme 0
49
10 years 0
Extreme 0
49
Manager TitleAgeSince
Chief Executive Officer 58 22/03/2022
Director of Finance/CFO 53 22/03/2022
Investor Relations Contact - 01/06/2022
Director TitleAgeSince
Chairman 58 11/02/2026
Director/Board Member 60 20/03/2022
Director/Board Member 58 01/04/2022
Date Insider Type Main position Quantity % Market Cap. Importance
04/09/26 Sell

Director

-6,293 0.0111%
12/08/26 Buy

General Counsel

20,000 0.0337%
12/08/26 Buy

Chief Financial Officer

20,000 0.0337%
Change 5-day change 1-year change 3-year change Capi.($)
+1.33%-14.74%-67.70%-69.42% 277M
-1.25%-5.94%-23.18%-0.54% 179B
-0.82%-3.70%-3.78%+11.41% 117B
-0.69%-3.46%+5.51%+79.76% 61.25B
-1.92%-6.01%+8.80%+41.11% 50.24B
+0.01%-4.77%-7.68%-34.15% 48.05B
-1.34%-5.39%+9.42%-22.49% 31.89B
-0.48%-12.27% - - 28.42B
+0.77%+1.55%+30.90%-13.07% 24.23B
+0.49%-7.65%-12.44%+4.86% 21.4B
Average -0.42%-6.06%-6.68%-0.28% 56.18B
Weighted average by Cap. -0.90%-4.25%-6.40%+10.50%

Financials

2026 *2027 *
Net sales 1.02B 881M 831M 757M 1.42B 97.95B 1.43B 9.9B 3.81B 49.68B 3.85B 3.76B 158B 1.08B 930M 878M 800M 1.49B 103B 1.51B 10.45B 4.02B 52.46B 4.06B 3.97B 167B
Net income 69.3M 59.6M 56.23M 51.23M 95.76M 6.63B 96.63M 670M 258M 3.36B 260M 255M 10.67B 76.83M 66.08M 62.34M 56.8M 106M 7.35B 107M 743M 286M 3.73B 289M 282M 11.83B
Net Debt - -
Logo Embecta Corp.
Embecta Corp. is a global medical device company. It provides solutions to improve the health and well-being of people living with diabetes. Its portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. It sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It distributes its products through channels, including retail, hospitals and pharmacies. It is also a manufacturer of medical devices and drug delivery technologies.
Employees
1,850
Date Price Change Volume
11/09/26 $4.940 +1.02% 142,689
10/09/26 $4.890 -4.49% 1,375,212
09/09/26 $5.120 -7.75% 1,528,205
08/09/26 $5.550 -4.31% 1,361,579
04/09/26 $5.800 +1.93% 1,001,178
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
4.890USD
Average target price
4.000USD
Spread / Average Target
-18.20%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EMBC Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!